CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04159207
NCT04159207N/ACompleted

A Longitudinal Study of Inflammatory Pathways in Depression

Van Andel Research Institute·observational·Posted Nov 12, 2019·Updated Apr 6, 2025

In Brief

An observational study for Major Depressive Disorder and Suicide, Attempted. Completed, enrolled 130 participants across 1 site.

Detailed Summary

Suicide accounts for at least 1 million deaths globally each year. This is likely a significant underestimate, because suicide is under-reported in many countries. In the US, over 42,000 people die from suicide annually. Despite increased focus on identification and treatment, the rate of suicide has increased steadily over the past 15 years. Our project aims both to improve our understanding of factors that increase the risk for suicide by comparing blood biomarkers associated with inflammation in patients with depression without suicidal behavior and patients with depression and suicidal behavior. The 160 individuals in this study will be followed with psychiatric assessments and blood samples at repeated time points over one year.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 12, 2019
Enrollment StartOct 1, 2019
Primary CompletionAug 30, 2023
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 6.6 years ago